Loading clinical trials...
Loading clinical trials...
A Randomized Multi-Center Phase III Study of Individualized Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as a Bridge to Transplant in Hepatocellular Carcinoma.
Conditions
Interventions
Stereotactic Body Radiation Therapy (SBRT)
Trans-Arterial Chemoembolization (TACE)
+1 more
Locations
5
United States
Lahey Hospital & Medical Center
Burlington, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Princess Margaret Hospital, UHN
Toronto, Ontario, Canada
Start Date
March 1, 2020
Primary Completion Date
February 28, 2024
Completion Date
February 28, 2024
Last Updated
August 28, 2024
NCT06345508
NCT06066138
NCT07485114
NCT06811116
NCT04380545
NCT07291076
Lead Sponsor
Lahey Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions